Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma
Clinical trial NCT04180995 · UNKNOWN
Trial details
- NCT number
- NCT04180995
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2022-07-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.